Ischemic penumbra: Evidence from functional imaging in man

Journal of Cerebral Blood Flow and Metabolism

Volumn 20, Issue 9, 2000, Pages 1276-1293

  Heiss, W D ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Critical ischemia; DW MRI; Irreversible damage; Multitracer PET; Penumbra; Perfusion CT; PW MRI; SPECT; Therapeutic trials; Xe CT

Indexed keywords

ANTITHROMBOCYTIC AGENT; LIGAND; RECEPTOR; TRACER;

BRAIN ISCHEMIA; CELL DAMAGE; CELL HYPOXIA; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FIBRINOLYTIC THERAPY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TISSUE PERFUSION;

EID: 0033848141     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200009000-00002     Document Type: Review

References (159)

1. Positron imaging in ischemic stroke disease using compounds labeled with oxygen 15. Initial results of clinicophysiologic correlations
2. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
3. Simple visual analysis of brain perfusion on HMPAO SPECT predicts early outcome in acute stroke
4. Thresholds in cerebral ischemia - The ischemic penumbra
5. Changes in cerebral tissue perfusion during the first 48 hours of ischemic stroke: Relation to clinical outcome
6. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging
7. Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography
8. Magnetic resonance imaging of acute stroke
9. Mapping the ischemic penumbra with PET: Implications for acute stroke treatment
10. Reversal of focal 'misery-perfusion syndrome' by extra-intracranial arterial bypass in hemodynamic cerebral ischemia
11. Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease
12. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window
13. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: A positron tomography study
14. Inflammatory mediators and stroke: New opportunities for novel therapeutics
15. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome
16. Differentiation between transient ischemic attack and ischemic stroke within the first six hours after onset of symptoms by using 99mTc-ECD-SPECT
17. 99mTechnetium-ethyl-cysteinate-dimer single photon emission CT can predict fatal ischemic brain edema
18. Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon
19. Diagnosis of acute cerebral infaction: Comparison of CT and MR imaging
20. Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: Contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging
21. Measuring cerebral blood flow using magnetic resonance imaging techniques
22. MR diffusion imaging of cerebral infarction in humans
23. Antagonizing excitotoxicity: A therapeutic strategy for stroke?
24. Rapid monitoring of changes in water diffusion co-efficients during reversible ischemia in cat and rat brain
25. Clinical trials with neuroprotective drugs in acute ischemic stroke: Are we doing the right thing?
26. The significance of cobalt-55 positron emission tomography in ischemic stroke
27. Pathobiology of ischemic stroke: An integrated view
28. Recently developed neuroprotective therapies for acute stroke: A qualitative systematic review of clinical trials
29. Xenon enhanced CT for analysis of cerebral integrity perfusion and blood flow
30. Evaluation of regional cerebral blood flow using single photon emission tomography for the selection of patients for local fibrinolytic therapy of acute cerebral embolism
31. Computed tomography findings in the first few hours of ischemic stroke: Implications for the clinician
32. Relation between cerebral blood flow and neurologic deficit resolution in acute ischemic stroke
33. Relationship between cerebral blood flow and the development of swelling and life-threatening herniation in acute ischemic stroke
34. Characterizing the target of acute stroke therapy
35. Application of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke
36. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: A randomized controlled trial
37. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra
38. Early computed-tomography abnormalities in acute stroke
39. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke
40. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke
41. Clinical sensitivity and specificity of diffusion weighted MRI in hyperacute stroke
42. Early X-ray hypoattenuation of brain parenchyma indicates extended critical hypoperfusion in acute stroke
43. The current status of neuronal protective therapy: Why have all neuronal protective drugs worked in animals but none so far in stroke patients?
44. Early CT changes of ischemia: Limitations of what we know
45. tPA-associated reperfusion after acute stroke demonstrated by SPECT
46. In vivo mapping of local cerebral blood flow by Xenon enhanced computed tomography
47. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II)
48. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative ECASS Study Group
49. The effect of nimodipine on the evolution of human cerebral infarction studied by PET
50. In vivo binding of nimodipine in the brain: I. The effect of focal cerebral ischemia
51. Value of single-photon emission-computed tomography in acute stroke therapeutic trials
52. Prolonged disturbances of regional cerebral blood flow in transient ischemic attacks
53. MRI diffusion mapping of reversible and irreversible ischemic injury in focal brain ischemia
54. Spreading waves of a reduced diffusion coefficient of water in normal and ischemic rat brain
55. Evaluation of cerebral infarction with iodine-123-iomazenil SPECT
56. Cerebral blood volume in acute brain infarction - A combined study with dynamic susceptibility contrast MRI and 99mTc-HMPAO-SPECT
57. Positron emission tomography imaging and the therapeutic window
58. The ischemic penumbra
59. Early detection of irreversibly damaged ischemic tissue by flumazenil-PET in cats
60. Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats
61. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke
62. Tissue at risk of infarction rescued by early reperfusion: A positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke
63. Cortical neuronal function during ischemia
64. Nimodipine improves glucose metabolism after stroke
65. Progressive derangement of periinfarct viable tissue in ischemic stroke
66. Early (11C)flumazenil/H2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy
67. Functional recovery of cortical neurons as related to degree and duration of ischemia
68. Which targets are relevant for therapy of acute ischemic stroke?
69. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: Evaluation with rCBF-SPECT
70. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: The relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances
71. Binding of hypoxia tracer (3H) misonidazole in cerebral ischemia
72. Viability thresholds and the penumbra of focal ischemia
73. Diffusion and perfusion MR imaging of cerebral ischemia
74. Effect of propentofylline on regional cerebral glucose metabolism in acute ischemic stroke
75. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: Early clinical results
76. Early recanalisation in acute ischemic stroke saves tissue at risk defined by MRI
77. Thresholds of focal cerebral ischemia in awake monkeys
78. Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth
79. Ischemic core and penumbra in brain stroke
80. Diffusion MRI in patients with transient ischemic attacks
81. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging
82. Imaging stroke in progress: Magnetic resonance advances but computed tomography is poised for counterattack
83. Effects of stroke on local cerebral metabolism and perfusion: Mapping by emission computed tomography of 18FDG and 13NH3
84. Comparative correlations of HMPAO SPECT indices, neurological score and stroke subtypes with clinical outcome in acute carotid infarcts
85. Cerebral blood flow quantitation in clinical routine studies: How far have we now come?
86. Diffusion MR imaging: Clinical applications
87. Does neuroprotection improve stroke outcome?
88. Comparison of mean cerebral transit time and single-photon emission tomography for estimation of stroke outcome
89. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke
90. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke. A correlative PET-CT study with voxel-based data analysis
91. Predictive value of 99mTc-HMPAO-SPECT for neurological outcome/recovery at the acute stage of stroke
92. Differential regional vulnerability in transient focal cerebral ischemia
93. Acute and chronic stroke: Navigated spin-echo diffusion-weighted MR imaging
94. Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI
95. Radiolabeled hypoxic cell sensitizers; tracers for assessment of ischemia
96. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats
97. High resolution three-dimensional measurement of localized cerebral blood flow by CT scanning and stable Xenon clearance: Effect of cerebral infarction and ischemia
98. Correlation between peri-infarct DC shifts and ischemic neuronal damage in rat
99. Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI
100. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats
101. Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats
102. Correlation of the average water diffusion constant with cerebral blood flow and ischemic damage after transient middle cerebral artery occlusion in cats
103. Meta-analysis of oral nimodipine trials in acute ischemic stroke
104. Early detection of regional cerebral ischemia in cats: Comparison of diffusion- and T2-weighted MRI and spectroscopy
105. Assessment of postischemic reperfusion and diamox activation test in stroke using 99mTc-ECD SPECT
106. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil
107. PET study of changes in local brain hemodynamics and oxygen metabolism after unilateral middle cerebral artery occlusion in baboons
108. MRI measurements of water diffusion and cerebral perfusion: Their relationship in a rat model of focal cerebral ischemia
109. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans
110. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation
111. Pathophysiology of acute ischemic stroke
112. Temporal profile of neuronal damage in a model of transient forebrain ischemia
113. The evolution of acute stroke recorded by multimodal magnetic resonance imaging
114. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole
115. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging
116. Recovery of apparent diffusion Coefficient after ischemia-induced spreading depression relates to cerebral perfusion gradient
117. Identification of collaterally perfused areas following focal cerebral ischemia in the rat by comparison of gradient echo and diffusion MRI
118. The effect of reperfusion therapy on cerebral blood flow in acute stroke
119. Evaluation of reperfusion and recovery of brain function before and after intracarotid arterial urokinase therapy in acute cerebral infarction with brain SPECT
120. Reduction of infarct volume by halothane: Effect on cerebral blood flow or perifocal spreading depression-like depolarizations
121. Complete recanalization via fibrinolytic therapy can reduce the number of ischemic territories that progress to infarction
122. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials
123. The ischemic penumbra - Operationally defined by diffusion and perfusion MRI
124. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke
125. Caspases as treatment targets in stroke and neurodegenerative diseases
126. Cellular regulation of the benzodiazepine/GABA receptor: Arachidonic acid, calcium, and cerebral ischemia
127. CT-perfusion imaging in acute stroke with MCA stem occlusion: Predicting outcome after intra-arterial thrombolysis
128. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon
129. Correlation of continuous electroencephalograms with cerebral blood flow measurements during carotid endarterectomy
130. Cerebral infarction within six hours of onset: Prediction of completed infarction with technetium-99m-HMPAO SPECT
131. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment
132. Hyperacute stroke: Evaluation with combined multisection diffusion-weighted and hemodynamically weighted echoplanar MR imaging
133. Hyperacute stroke: Simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time
134. Quantitation of diffusion/perfusion MRI mismatch in acute human cerebral infarction
135. 55Cobalt (Co) as a PET-tracer in stroke, compared with blood flow, oxygen metabolism, blood volume and gadolinium-MRI
136. The role of spreading depression in focal ischemia evaluated by diffusion mapping
137. Positron emission tomographic measurement of acute hemodynamic changes in primate middle cerebral artery occlusion
138. Tissue plasminogen activator for acute ischemic stroke
139. Hemorrhagic transformation of brain infarct: Predictability in the first 5 hours from stroke onset and influence on clinical outcome
140. Sequential studies of severely hypometabolic tissue volumes after permanent middle cerebral artery occlusion. A positron emission tomographic investigation in anesthetized baboons
141. Progressive impairment of brain oxidative metabolism reversed by reperfusion following middle cerebral artery occlusion in anesthetized baboons a quantitative analysis of infarction volume
142. Evaluation of peri-infarcted hypoperfusion with T2-weighted dynamic MRI
143. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT
144. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography
145. The application of magnetic resonance imaging to the study of experimental cerebral ischemia
146. Acute stroke: Usefulness of early CT findings before thrombolytic therapy
147. Interobserver agreement in assessing early CT signs of middle cerebral artery infarction
148. Fast magnetic resonance diffusion-weighted imaging of acute human stroke
149. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging
150. A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging
151. Serial observations on the pathophysiology of acute stroke
152. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET
153. Ischemic penumbra in acute stroke: Demonstration by PET with fluorine-18 fluoromisonidazole
154. Side effects of Xenon inhalation
155. Stable Xenon enhanced CT measurement of cerebral blood flow in reversible focal ischemia in baboons
156. Diffusion-weighted magnetic resonance imaging: Detection of ischemic injury 39 minutes after onset in a stroke patient
157. Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion: An investigation in anesthetized baboons with positron emission tomography
158. Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion
159. MR imaging of cerebral ischemia: Findings in the first 24 hours